TrialHaematologica2025

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.

Nirav N Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.